IVIM Health vs Fridays vs Mochi Health (2026)

On tirzepatide, the order is IVIM Health↗ ($278) → Mochi Health↗ ($278) → Fridays ($359) — gaps of $0 and then $81 a month, a $972 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

IVIM Health: the record, condensed

Start with the load-bearing figure: $278 a month, all-in, is what IVIM Health charges for tirzepatide at the 10 mg basis. Note the shape: $208 is the number in the marketing, $278 is the number at maintenance. The $70 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

A required $75/month membership is part of the deal, and part of the figure above: $203 of medication plus $75 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #3 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

IVIM Health’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

Inside that $149 sits a mandatory $75-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $74, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #3 of 20 in the verified semaglutide index — $16/month above the floor (Oak Longevity, $133) — and sits $200 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $1,788.

Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗

Mochi Health: the record, condensed

Start with the load-bearing figure: $278 a month, all-in, is what Mochi Health charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Inside that $278 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $199, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #4 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.

Start with the load-bearing figure: $178 a month, all-in, is what Mochi Health charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Inside that $178 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #8 of 20 verified programs, with the floor $45/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $171 a month. A year at this figure: $2,136 monthly-billed.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

Fridays: the record, condensed

On tirzepatide, the number that matters at Fridays is $359 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

Context for that figure: it ranks #13 of 17 in the verified tirzepatide index — $144/month above the floor (NexLife, $215) — and sits $90 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,308.

Start with the load-bearing figure: $175 a month, all-in, is what Fridays charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $175 is the whole subscription, which makes Fridays unusually easy to compare and unusually easy to leave.

To place the number: #7 of 20 verified programs, with the floor $42/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $174 a month. A year at this figure: $2,100 monthly-billed.

Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗

§ The three-way read

Prices, gaps, and what sits inside them

IVIM Health holds the low ground at $278 (its $75 membership already inside). Mochi Health follows at $278 (+$0/mo, $0/yr), membership included. Fridays tops the trio at $359 (+$81/mo over the leader, $972/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles nothing: IVIM Health $149 → Fridays $175 → Mochi Health $178 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: IVIM Health ($278); cheapest 12-month path: IVIM Health ($3,336); simplest billing (no membership): Fridays; dose-flat structure: Mochi Health and Fridays; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: IVIM Health ($149).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: IVIM Health vs Mochi Health · IVIM Health vs Fridays · Mochi Health vs Fridays.

§ Structure, three ways

Everything besides the three prices

Memberships: IVIM Health $75/mo (inside its figure); Mochi Health $79/mo (inside its figure); Fridays none. Structures: IVIM Health step/tiered; Mochi Health dose-flat; Fridays dose-flat. Pharmacies: IVIM Health not named; Mochi Health named (company-owned compounding facility); Fridays not named. States: IVIM Health — not published; Mochi Health — most states; Fridays — not published. Exit terms: IVIM Health — membership mandatory; Mochi Health — cancel membership any time; recurs until cancelled; Fridays — not published.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: IVIM Health source-verified (2026-08-05); Mochi Health source-verified (2026-08-05); Fridays third-party reported (2026-08-05).

The trio on semaglutide, across time

3 mo: IVIM Health $447 vs Fridays $525 vs Mochi Health $534 6 mo: IVIM Health $894 vs Fridays $1,050 vs Mochi Health $1,068 12 mo: IVIM Health $1,788 vs Fridays $2,100 vs Mochi Health $2,136 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

IVIM Health: $3,336/yr monthly-billed; Mochi Health: $3,336/yr monthly-billed; Fridays: $4,308/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,944 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

A three-way choice is really two eliminations, so run them in order. Eliminate Fridays first unless it names its edge: at $359 it carries a $81/month premium over the floor of this trio — $972 a year, about 3.5 extra months of therapy at IVIM Health’s rate — and a premium that size must point at a specific line in its record (its particular program design) or it is decoration. Then interrogate Mochi Health’s middle ground: its dose-flat structure removes titration repricing; if that specific thing is on your personal ledger, the $0/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is IVIM Health at $278, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.

The same trio on best published rate: IVIM Health $278 → Mochi Health $278 → Fridays $359 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — IVIM Health $834, Mochi Health $834, Fridays $1,077; 6 months — IVIM Health $1,668, Mochi Health $1,668, Fridays $2,154. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): IVIM Health 4/5, Mochi Health 5/5, Fridays 3/5. Mochi Health discloses the most and Fridays the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. Where the trio actually splits: pharmacy named: Mochi Health yes, IVIM Health and Fridays no — each split is a written intake question before any card number. Scores recompute from the public records like everything else here.

Read as a decision: start from IVIM Health and make the other two argue upward. Mochi Health’s case is its structure; Fridays’s case must be worth $972 a year in named features — the honest unit being months of medication (3.5 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.